Highlights of ACTAs activity and achievements during the 2021 – 2022 Financial Year.
Resource Documents
ACTA 2021-2022 Annual Report
Latest Resource
-
HEAT Webinar Recording- Use of Administrative Data for Measuring Events and Healthcare Use
-
Approaches to prioritising research
for clinical trial networks: a scoping review -
HEAT Webinar Recording- Economic Evaluation Alongside Adaptive Trials
-
Effective strategies to manage data integrity risks webinar
-
The Data Lifecycle: Ethical use of data webinar
-
Transparency in data analyses webinar
-
Economic evaluation alongside cluster trial – webinar recording
-
Resource for trial statisticians planning to apply for an academic promotion
-
Nurse- and midwife-led trials in Australia and New Zealand: Scoping review protocol
-
Development of the Consumer Involvement and Engagement Toolkit
-
Activities supporting the growth of Clinical Trial Networks in Australia
-
A pilot study to prospectively estimate the health and economic return on research investment
-
A snapshot of consumer engagement in clinical trials in Australia
-
Strengthening the capacity, efficiency and effectiveness of Clinical Trials Networks: Activity Overview 2017–2021
-
Implementability Guidance Document: After The Trial
-
ACTA 2020-2021 Annual Report
-
Assessing the impact of clinical trials: a scoping literature review
-
Fundraising strategy: guidance for CTNs
-
Communications and marketing strategy: guidance for CTNs
-
Research Prioritisation Uncovered – Workshop 2 recording
-
Research Prioritisation Uncovered – Workshop 1 recording
-
Normalising comparative effectiveness trials as clinical practice
-
HeSANDA initiative stakeholder consultation project – final report
-
Communications and Marketing for Clinical Trials Networks: Website content management systems (CMS)
-
Communications and Marketing for Clinical Trials Networks: Social Media
-
Communications and Marketing for Clinical Trials Networks: Email Marketing
-
Communications and Marketing for Clinical Trials Networks: Data Dashboards
-
HeSANDA initiative stakeholder consultation project – Executive Summary of key findings
-
Understanding implementability in clinical trials: a pragmatic review and concept map
-
ACTA Report on the feasibility of a proportionate approach for comparative effectiveness research in Australia
-
ACTA Integrated Consent User Guide and Template
-
ACTA Discussion Paper: integrated consent – a tiered approach to consent for comparative effectiveness trials
-
ACTA Whistleblower Policy
-
HeSANDA Stakeholder Consultation Project
-
Protocols and Statistical Analysis Plans (SAPs) for Adaptive Trials
-
MEDIA RELEASE: ACTA appoints Prof Steve Webb as its new Chair and Ian Wilson as Additional Independent Director